CD274 and neoplasm: In addition to butyrate-producing bacteria, other probiotics such as Akkermansia muciniphila and Bifidobacterium have also been shown to enhance PD-1/PD-L1 blockade efficacy by reshaping metabolic profiles and optimizing the tumor immune microenvironment.